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The  aim  of  this  review  was  to assess  public  knowledge  and  behaviours  in relation  to antibiotic  use  in  GCC
countries.  A  systematic  review  was  performed  using  MEDLINE,  EMBASE  and  other  relevant  databases.
Cross-sectional  studies  published  from  January  2000  to  June  2017  relating  to  public  knowledge  and
behaviours  towards  antibiotic  use  were  included.  Overall  nine  studies  met  the  inclusion  criteria  for  this
systematic  review.  Nearly  half  of  general  public  respondents  in  the  GCC  region  reported  a lack  of  knowl-
edge about  antibiotic  use and  showed  negative  attitudes  towards  antibiotic  utilisation.  Penicillin  was  the
most frequently  misused  antibiotic,  particularly  for self-medication.  Most  respondents  declared  that  theyehavior
ntibiotic
ntibacterial
ulf countries
obtained information  on  antibiotics  from  pharmacists.  Pharmacies  were  the  major  source  of  antibiotics
used  for  self-medication.  A multi-disciplinary  approach  must  be  put  in  place  to  educate  the public  on
appropriate  antibiotic  use,  to improve  policies  regarding  the  rational  prescription  of  antimicrobials  and
to  increase  regulation  enforcement.
© 2018  The  Authors.  Published  by Elsevier  Limited  on  behalf  of King  Saud  Bin Abdulaziz  University
for  Health  Sciences.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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ing antibiotic use for a particular illness, were excluded because of
their potential to limit the generalisability of the findings. A PRISMA
diagram detailing the study identification and selection process is
given in Fig. 1.ntroduction
It is a well-known fact that antibiotics are one of the largest
oons of modern life. They have, since their discovery, been a poten-
ial source of life-saving drugs. However, antibiotics are hampered
y the tendency of bacteria to rapidly develop “resistance” that
esults in the failure of the treatment [1]. In contrast to many other
ealth problems, antimicrobial resistance (AMR) is an issue that
oncerns all countries, irrespective of their level of development
nd income [2]. Therefore, the World Health Organisation (WHO)
escribed AMR  as a main “global security threat” which could send
edicine to a “post-antibiotic era” [2]. Similar to other countries
orldwide, there is some evidence indicating that AMR  constitutes
 global challenge in the Gulf Cooperation Council (GCC) coun-
ries [3]. The GCC countries are an economic and political union.
onstituent countries include; the Kingdom of Bahrain, Kuwait, Sul-
anate Oman, Qatar, the Kingdom of Saudi Arabia and United Arab
mirates (UAE). Many studies have revealed that AMR in differ-
nt bacterial species has increased over the last decade in different
egions of the GCC countries [4,5]. Therefore, identifying public
nowledge and behaviours towards antibiotic use plays a key role in
he success of tackling AMR  [6,7]. Several lines of evidence suggest
hat understanding patients’ knowledge and behaviour facilitates
ore efficient communication between the patient and clinician
8]. Secondly, since heterogeneity is sometimes required in public
ealth interventions due to the fact that ‘one size does not fit all’,
herefore a better understanding people’s perceptions, knowledge
nd attitudes towards antibiotic usage among a specific population
s important for implementing effective public health interven-
ions that meet needs and fit the specific requirements of the
arget group [9]. Despite the importance of evaluating the public
nowledge and behaviour regarding antibiotics, to date, there does
ot appear to be a systematic review on public knowledge and
ehaviour towards antibiotics in the GCC countries. Considering
he magnitude of challenges that can stimulate the emergence and
pread of AMR, the high prevalence of AMR, the lack of knowledge
bout antibiotics use and inappropriate use of antibiotics in the GCC
ountries context, efforts examining research from GCC countries
n particular are urgently required. Thus, this systematic review
as performed to assess the public knowledge and behaviours in
elation to antibiotics among the general public in GCC countries.
nformation on the antibiotics frequently misused and sources of
ntibiotic information, recommendations and supply are also sum-
arised.able 1
 list of the search terminology used in literature review.
Search terms for
‘Public’
AND Search terms for
‘Knowledge’
AND Search terms for
‘behaviour’
Public* OR People* OR
general population OR
community
knowledge OR belief*
OR awareness or view*
OR perception
Behave* OR attitude*
or use OR utili* OR
practiceMaterials and methods
Data sources, search terms, and search strategy
MEDLINE (PubMed); AMED (Allied and Complementary
Medicine) (via EBSCO); ASSIA (Applied Social Sciences Index and
Abstracts) (via Proquest); BioMed Central; CINAHL Plus (Cumula-
tive Index to Nursing and Allied Health Literature) (via EBSCO); and
EMBASE were searched between 7 August 2017 and 3 September
2017. To emphasise the validity of the search strategy, multiple
websites were systematically searched, including relevant online
journals, Google Scholar and Researchgate. Reference tracing of the
bibliographies of all related studies was conducted to emphasise
the sensitivity of the original search strategy. Contacting authors
of articles and organisations in the field was  conducted to identify
unpublished studies. Search terms were derived from main five
keywords: ‘public’; ‘knowledge’; ‘behaviour’; ‘antibiotic’ and ‘Gulf
Cooperation Council countries’. The search strategy is outlined in
Table 1.
Selection criteria
The inclusion criteria for this review were the following: (1)
cross-sectional studies; (2) published from January 2000 to June
2017; (3) relating to public knowledge and behaviour towards
antibiotic use; (4) people of any age from the general public
(including residents (i.e. people who  live in the GCC region) and
non-residents (i.e. people who  mainly resides in one region or juris-
diction but has interests in the GCC region such as visitors); (5)
written in English or Arabic languages; (6) Full-text articles and
original research. Studies that included healthcare professionals
participating in research while representing their profession were
excluded. All articles focusing on public knowledge and behaviours
in relation to antivirals, antifungals, antiprotozoals, and topical
antimicrobials use or in relation to the problem of AMR  or any other
information not related to participants’ knowledge and behaviours
towards antibiotic utilisation were excluded. Studies that reflected
the practice of self-medication with antibiotics studies that mea-
sured community behaviour only or practices only and those that
did not determine knowledge behaviours were excluded. Stud-
ies including a survey that focused only on a specific population
group (e.g. patients, caregivers, and parents), and those concern-AND Search terms for
‘antibiotic’
AND Search terms for ‘Gulf Cooperation
Council countries’
Antibiotic* OR AMs* OR
Antimicrobial* OR
Antibacterial
Gulf Cooperation Council countries
OR GCC states OR Saudi Arabia OR
Kuwait OR Bahrain OR Qatar OR
Oman OR United Arab Emirates
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tudy selection and quality assessment
One author RA assessed the search results to find potentially
ligible studies. All search histories were merged using RefWorks
nd examined. The duplicates were removed as the first stage
identification). The next step (screening) was to screen citations
ased on the title and abstract provided, and only eligible stud-
es were selected. The third stage (eligibility) involved obtaining
he full-text articles for further investigation of relevance to the
ligibility criteria. The fourth stage (included) was the conduct-
ng of a final scrutiny of the remaining studies (Fig. 1). For studies
here eligibility was unclear, EB was invited to provide feedback
nd any disagreement was resolved with a discussion. The quality
ssessment process was conducted by RA using the Milton Keynes
rimary Care Trust (2002) assessment tool [10]. The included stud-
es were each graded by the general grading system A, B, C. One
ark was allocated for each (Yes) answer. Then, the total score was
alculated and divided by the total number of items multiplied by
00. Studies that scored from 0 to 40% were considered C, 41 to
0% were considered B, and 71 to 100% were interpreted as A. Thentification and selection process.
authors chose to reject (C) grade papers from further inclusion in
this review.
Data extraction and synthesis of results
Data extraction was  performed by RA Information on the year
of publication, country, sample size, setting, population, ques-
tionnaire administration process, response rate and participants’
gender and age were extracted — as presented in Table 2. Data
related to review objectives are illustrated in Table 3. Due to
heterogeneity in the studies that met  the eligibility criteria, a
meta-analysis was  not possible, so a narrative synthesis was under-
taken.
Results
Study selectionA total of 422 studies were sourced electronically. A further six
studies were identified through reference list searching, and eleven
through purposive searching, totalling 439. 130 duplicates were
162 R.A. Almohammed, E.L. Bird / Journal of Infection and Public Health 12 (2019) 159–166
Table 2
Characteristics of the studies included.
Study Country Sample
size (n)
Response
rate (%)
Questionnaire
administration
Setting Population Age
(years)
Gender
F (%) M (%)
Abdelrahman et al. [11] Saudi Arabia 1028 NM Face-to-face interview &
internet-based-survey
NM General public All ages 28.5 71.5
Ajwah  et al. [12] Saudi Arabia 211 NM Self-administered Street, homes General public 19–30 62.2 37.8
Awad  and Aboud [13] Kuwait 770 88.3 Self-administered Ministries, universities,
schools, and healthcare
centers
General public 21–79 68.7 31.3
Belkina et al. [14] Saudi Arabia 400 NM Face-to-face interview High schools High school
teachers
All ages 84 16
El  Zowalaty et al. [15] Saudi Arabia 1310 87.7 Face-to-face interview Public areas, clinics,
hospitals, houses, and
universities
General public Over 18 59 41
Emeka et al. [16] Saudi Arabia 489 80.66 Face-to-face interview NM General public 18–59 21.4 78.6
Jose  et al. [9] Oman 718 85 Self-administered NM General public 18–60 54 46
Moienzadeh et al. [17] Qatar 596 65 Self-administered Community pharmacies General public Over 18 58.8 41.2
Nafisah et al. [18] Saudi Arabia 473 98.75 Self-administered Coffee shops, universities, a
high school, and a
secondary hospital
General public All ages 55.8 44.2
NM,  not mentioned; n, number. (No missing values were inferred).
Table 3
Methodological quality of included studies.
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 % Grade MA
Abdelrahman et al. [11] 1 1 0 1 0 0 0 1 1 1 60 B Y
Ajwah et al. [12] 1 1 0 0 1 0 0 1 1 1 60 B Y
Awad  and Aboud [13] 1 1 1 1 1 1 1 1 1 1 100 A Y
Belkina et al. [14] 1 1 0 0 1 1 1 1 1 0 70 B Y
El  Zowalaty et al. [15] 1 1 1 1 1 0 1 1 1 1 90 A Y
Emeka et al. [16] 1 1 1 1 0 1 0 1 1 1 80 A Y
Jose  et al. [9] 1 1 1 1 0 1 1 1 1 1 90 A Y
Moienzadeh et al. [17] 1 1 1 1 1 0 1 1 1 1 90 A Y
Nafisah et al. [18] 1 1 1 1 1 1 1 1 1 1 100 A Y
MA,  methodologically accepted; Y, yes.
Q1 = Did the study address a clearly focused issue?
Q2  = Did the authors use an appropriate method to answer their question?
Q3  = Were the subjects recruited in an acceptable way?
Q4 = Were the measures accurately measured to reduce bias?
Q5  = Were the data collected in a way that addressed the research issue?
Q6 = Did the study have enough participants to minimize the play of chance?
Q7  = Did the authors take sufficient steps to assure the quality of the study data?
Q
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e8 = Was  the data analysis sufficiently rigorous?
9 = Is there a clear statement of findings?
10 = Can the results be applied to the GCC population?
xcluded. The remaining 309 studies were subjected to stage two
screening), of which 288 were excluded for the following reasons:
rrelevant (n = 270), evaluating healthcare workers’ knowledge and
ttitudes in relation to antibiotics (n = 15) and abstract-only form
n = 3). Overall 21 studies were passed through for stage three (eli-
ibility). Twelve studies were excluded for the following reasons:
elf-medication studies measured community behaviour and prac-
ices only and did not determine knowledge, attitudes or beliefs
n = 4), not conducted in the GCC countries (n = 4), involved a survey
hat focused only on patients (n = 1), concerned antibiotic use for
 specific illness (upper respiratory infection) (n = 2) and included
 survey that focused only on parents (n = 1). A final scrutiny of
he full texts of the remaining nine studies was  conducted. All
ine studies met  the eligibility criteria and were included in this
eview [9,11–18]. The PRISMA flow diagram was used to illustrate
he identified eligible studies (Fig. 1).
haracteristics of eligible studiesDescriptive data extracted from the nine included studies is
eported as an overview summary (Table 2). The studies cov-
red 5995 participants of different ages. The response rate variedfrom 65% to 98.8% in the included studies that reported it. The
sample size ranged from 211 to 1310. Additionally, data collec-
tion methods for the included studies varied from questionnaires,
mixed methods using questionnaires and interviews to gathering
information from the respondents. Also, the settings ranged from
people’s homes to community-based settings. The study duration
varied among the different studies, ranging from 1 month to 11
months. The majority of the studies (67%) were performed in Saudi
Arabia [11,12,14–16,18]. The remaining studies (33%) were con-
ducted in Qatar [17], Oman [9] and Kuwait [13]. The residency
status of the participants was  not mentioned in any of the included
studies.
Quality assessment
The assessment of the methodological quality of the included
studies is summarised in Table 3. Six studies (67%) were consid-
ered to be of good overall quality (A) [9,13,15–18]. Three (33%) were
assessed to be of fair quality (B) [11,12,14]. The mean methodolog-
ical score was 82% (SD15.6%); the threshold for acceptable study
quality was determined 41%. Under this ruling, all studies were
deemed methodologically acceptable.
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nowledge concerning antibiotics’ role
Overall, a lack of knowledge on antibiotic utilisation was
etected. Across all the studies that measured knowledge and
wareness of antibiotic utilisation, approximately half of partici-
ants though that antibiotics can be used for various non-bacterial
nfections and diseases [9,11–18]. Evidence revealed that the per-
entage of participants who did not know that antibiotics are not
seful for viral infections ranged from 36% to 46% [13–15,17,18]
nd for colds ranged from 19% to 55% [9,11,13,16,17]. However, the
ercentage of participants who thought that antibiotics could be
sed for coughs ranged from 25% to 52% [9,13,14]. On the other
and, evidence from only two studies revealed that the percentage
f participants who agreed that antimicrobials can treat bacterial
nfections ranged from 68% to 73% [11,17] (Table 4).
ntibiotic usage
The overall prevalence of people who had self-medicated
ntibiotics ranged from 14% to 73% [9,12,13,15–18]. The high-
st prevalence of self-medication was reported in Saudi Arabia
55%) [12,15,16,18], followed by Kuwait (28%) [13], Oman (18%)
9] and Qatar (14%) [17]. According to adherence to antibiotic
ourses, a high prevalence of participants who being prescribed
n antibiotic did not complete their antibiotic course as prescribed,
hich ranged from 30% to 72% [9,11–13,15,17,18]. The commonly
eported reason for not completing antibiotic courses was feel-
ng better [9,11,13,15,17,18], followed by thinking the antibiotic
oes not work [9,12,15]. With regard to storing antibiotics, a high
ercentage of participants stored antibiotics at home from uncom-
leted courses, even sometimes beyond the expiration date, which
anged from 17% to 77% [9,11–13,15–17]. However, the percentage
f participants who had shared their antibiotics with family mem-
ers or friends ranged from 20% to 50% [9,11,12,17,18] (Table 4).
ntibiotic misuse
Two methodologically sound studies provided information
bout the antibiotics most frequently misused, particularly those
sed in self-medication [15,16]. Penicillin was  the most fre-
uently misused antibiotic, followed by macrolides, metrodinazole,
ephalosporins, fluoroquinolones, and tetracyclin, as disclosed
y participants. Among the penicillin used, amoxicillin and its
ombination with clavulanate were used by the majority of the
articipants.
ources of antibiotic information, recommendations and supply
The Gulf Arab countries’ populations acquired information
bout antibiotics, especially those used for self-medication, from
ifferent sources. Evidence revealed these to include pharmacists
11,14,16,18], other sources (e.g. previous successful experi-
nce with the same antibiotic, internet and advertisement)
11,12,14,16], followed by a family/friend member [11,12,14,16].
urthermore, most of the antibiotics used for self-medication had
een obtained from pharmacies [12,13] followed by a friend or
amily member [13].
iscussion
This systematic review was designed to gather different studies
ublished from January 2000 to June 2017 that assessed gen-
ral public knowledge and behaviours towards antibiotic usage
n the GCC region. To the best of the authors’ knowledge, this
tudy is the first systematic review on this issue. The analysesn and Public Health 12 (2019) 159–166 163
conducted on nine different outcomes showed the following inter-
esting results. This review found that nearly 40% of participants
incorrectly thought that antibiotics work on most minor ailments,
such as the common cold and cough, all of which can be self-
limiting with suitable medical and supportive care. This result is
comparable with findings concerning the European countries [19]
and findings from many countries outside of the GCC [20]. Fur-
thermore, this review revealed confusion among participants about
whether antibiotics are effective against viruses or bacteria. Forty-
four percent of participants did not know that antibiotics have no
significant therapeutic effects on viruses, which is closely aligned
with a previous review, which reported results from European
countries [19]. These findings could be explained by an incomplete
understanding of and misperceptions about whether antibiotics are
effective against common colds and coughs, viruses, and bacteria.
The general public’s lack of knowledge about the correct utilisa-
tion of antibiotics could increase the number of requests for these
drugs from general practitioners for illnesses in which antimicro-
bials are not useful. Accordingly, there was  some evidence that the
patient could affect the physician in antibiotic prescribing, as an
over request could mean an over prescription [21]. This explains
why common diseases (e.g. colds and coughs) account for 75% of
the total antibiotic prescriptions [22].
Regarding public behaviours towards the sources of antibiotics,
many people of the GCC countries’ populations had self-medicated
with antibiotics. It is worth mentioning that a high prevalence of
those who self-medicated with antibiotics were reported to be from
Saudi Arabia, which ranged between 41% and 73% [12,15,16,18].
The higher rate of self-medication in Saudi Arabia compared to
other GCC countries could be associated with many factors. Firstly,
the presence of the cities of Makkah and Madinah in Saudi Ara-
bia, which are the focus of pilgrimage for Muslims from all over
the globe, could be a major factor [23,24]. This is because the
extreme congestion of people in those religious cities facilitates
the appearance and global spread of several infectious diseases,
which may  increase the probability of the inappropriate use of
antibiotics, including self-medication. Secondly, the market cost of
medications in Saudi Arabia is determined by a centrally controlled
committee at the Ministry of Health, which makes it the most cost-
effective option, and therefore, many medications are available at
low cost [25]. That could be an important factor for increasing the
inappropriate use of antibiotics, because most medications are not
covered by prescription plans or health insurance and so the patient
self-pays for outpatient treatments [25]. The overall median pro-
portions of self-medication reported in this review the figure was
45%, which is lower than that reported in studies from other Middle
Eastern countries; namely, Palestine [26] and Yemen [27], which
ranged between 56% and 78%, where the prevalence rates are more
alarming. In contrast, some developed countries in Europe have
much lower prevalence rates of self-medication, ranging from 1%
to 4% [28]. This can in part be linked to the over-the-counter antibi-
otic sales and antibiotic prescriptions being strictly regulated in
developed countries such as those of Europe. Also, it could in part
be associated with the effectiveness of antibiotic stewardship pro-
grammes and national strategic plans in developed countries.
Furthermore, findings from this review support existing evi-
dence that pharmacies are the main source of antibiotics used for
self-medication in Middle Eastern countries [29]. Moreover, this
review supports existing evidence that pharmacists, among other
healthcare professionals, are the source of antibiotics information
and supply in Middle Eastern societies; therefore, they are respon-
sible for the extensive inappropriate use of antibiotics [30]. The
provision of information about antibiotics without reliable infor-
mation on the diagnosis, patient history and physical examination
could potentially expose the patient to the risk of inappropriate
drug use. Hence, pharmacists play an important role, particularly in
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Table 4
Summary of results for the knowledge concerning antibiotic role and attitudes towards antibiotics.
Study Knowledge Behaviours
Reasons for using antibiotic therapy Source of antibiotics Adherence to an antibiotic courses Action and use
Bacterial
infection
(%)
Viral
infection
(%)
Cough
(%)
Cold
(%)
Othersa
(%)
Prescribed
(%)
Non-
prescribed
(%)
Complete
(%)
Not complete Sharing
antibiotics
(%)
Keeping
antibiotics
(%)
(%) Reasons
Feeling
better
(%)
Does not
work (%)
Othersb
(%)
Abdelrahman et al. [11] 73 NR NR 41 69 62 NR NR 52 52 NR NR 26 52
Ajwah  et al. [12] NR NR NR NR 27 39 41 39 72 NR 21 NR 50 34
Awad  and Aboud [13] NR 46 25 55 55 NR 28 65 36 68 NR 33 NR 44
Belkina et al. [14] NR 41 52 NR 54 52 48 48 NR 39 13 NR NR 46
El  Zowalaty et al. [15] NR 48 NR NR 18 NR 64 39 71 71 NR NR NR 45
Emeka et al. [16] NR NR NR 19 41 NR 73 NR NR NR NR NR NR 77
Jose  et al. [9] NR NR 39 39 39 NR 18 66 30 53 36 NR 40 17
Moienzdeh et al. [17] 68 47 NR 44 59 NR 14 NR 30 30 NR NR 37 55
Nafisah et al. [18] NR 36 NR NR 46 NR 48 NR 40 40 NR NR 20 NR
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a Others = genitourinary infections, superficial wounds, respiratory disease, asthm
b Others = forget to take antibiotic, side-effect.
iddle Eastern societies, in educating patients, stopping antibiotic
ales without a prescription and rationalising antibiotic usage.
In terms of drug use, this review found that amoxicillin and
he amoxicillin-clavulanic acid combination were the most com-
on sort of medications, as disclosed by respondents. Remarkably,
ndue utilisation of penicillin is also observed in all Middle Eastern
ountries [29]. No doubt the business-oriented attitude of prac-
itioners [31], which is caused by the non-compliance with the
xisting dispensing laws and the consumers’ desire to treat them-
elves without consultations, could be the main reason of the
imilar antibiotic patterns in other societies. Perhaps the high use
f penicillins without prescription might be because of penicillin’s
idespread reputation among people, the fact that it does not have
psetting side effects – unlike other classes of antibiotics – and its
ow cost [32].
The current findings revealed that sources of obtaining antibi-
tics beyond the pharmacist included family members and friends.
his is confirmed; a median of 37% of the study participants indi-
ated that they had given an antibiotic to someone else to use
ithout a medical consultation. Moreover, nearly half of respon-
ers store left-over antibiotics at home for future use, even often
eyond the expiry date, and later sharing these antibiotics with
thers or self-medicating. These findings demonstrated that a high
ercentage of the GCC countries’ populations share used antibi-
tics with others and store antibiotics at home from uncompleted
ourses, thus subjecting the general public to an increase in the
roblem of the inappropriate use of antibiotics. With regard to
dherence to antibiotic courses, findings from this review showed
vidence of a median of 40% of those being prescribed antibiotics
ot completing the course of antibiotics as prescribed. This pattern
f inappropriate use in regard to adherence to antibiotic courses
ay put the patient at risk of relapse with resistant pathogenic
acteria.
tudy strengths and limitations
This study is the first systematic review to assess the gen-
ral public’s knowledge and behaviours towards antibiotic usage
n the GCC region. Additionally, through adopting systematic
eview methodology this review presents a transparent account
f eligibility, quality assessment and data extraction. The current
eview also had some limitations. For example, the data collec-ne, fever, miscellaneous, pain relief, prophylactic use.
tion process, the estimates of findings were obtained through
self-report, potentially leading to information bias as participants
may  not precisely report or remember their activity. Although
the research question specifies “GCC countries”, two  GCC coun-
tries were not captured in the review (i.e. Bahrain and UAE) due
to the lack of studies conducted in these countries. However,
in the case of knowledge and behaviours towards antibiotic use
among populations in the GCC countries, the ability to gener-
alise broadly to the whole population of GCC region could be
viewed as suitable. One could argue that the whole population
of GCC countries share similar economic, socio-political, cultural,
and religious backgrounds [33,34]; therefore, the act of painting all
GCC populations with the same brush could be suitable. Despite
these limitations, the findings from the study add considerable
insight to existing literature on antibiotic use among the GCC coun-
tries.
Implications of the findings of this review for further research
Much further investigation is required, particularly at other lev-
els of influence (i.e. institutional, community, international, and
national levels). Therefore, more research agendas are needed,
as follows: Further research in UAE and Bahrain would be nec-
essary to determine whether the inference that has been drawn
cuts across all GCC populations, irrespective of their geographi-
cal regions. Further studies that seek to identify any other factors
that have a negative impact on the use of antibiotics in GCC coun-
tries (e.g. socioeconomic status, educational level, age, gender) are
also recommended. Perspectives of pharmacy staff, pharmacists
and personnel who  supply antibiotics need to be included in fur-
ther research to emphasise their roles in the appropriate use of
antibiotics. This would highlight the impact of the ease of obtaining
antibiotics without prescription on the use of antibiotics. Further
research should focus on other variables of the appropriate use of
antibiotics, such as access to healthcare services, the role of health
practitioners, and regulations relating to antibiotic supply and dis-
tribution.Implications of the findings of this review for policy and practice
At a public level, antimicrobial stewardship programmes can
address the misconception about antibiotic use by emphasis-
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ng the differences between viruses and bacteria and providing
xamples of common infections caused by each one. In view of
hat, the public would understand that most colds and coughs
re caused by viruses, which antibiotics are ineffective for. At
he individual level, clinicians could use efficient strategies –
or example, shared decision making [35] – to educate people
bout their actual risk of antibiotic resistance following antibi-
tic usage and provide information on how this resistance could
e avoided. The findings of this study also highlight the need
or good communication between clinicians and patients for sup-
orting adherence and appropriate use. Further, in view of the
act that inappropriate use of antibiotics is also triggered by
ver-prescription of antibiotics or dispensing antibiotic without
rescription, it is therefore essential that educational initiatives
arget prescription providers and antibiotic dispensers or phar-
acists. For instance, European Antibiotic Awareness Day, which
as been organised by the European Centre of Disease Preven-
ion and Control every year since 2008, confirms the need for
oth European citizens and healthcare providers to utilise antibi-
tics responsibly [36]. Findings from this review adds to existing
vidence that among the GCC populations Saudis self-medicate
ore; therefore, efforts should be made to target Saudi individ-
als.
Healthcare systems in both the private and public sectors
n the GCC countries should improve their policies regarding
he rational prescription of antimicrobials. Since pharmacists are
he main source of antibiotic information to the GCC popula-
ions [11,14,16,18], the implementation of pharmaceutical care
n each community pharmacy would help to increase the level
f awareness of antibiotic usage, which is now poorly developed
n the GCC region. The present regulations in the GCC coun-
ries decree that antibiotics are prescription-only medicines [25];
herefore, they must only be bought upon presenting a suit-
ble prescription. The regulation also decrees that pharmacies
re the only official sellers of antimicrobials. However, findings
rom this review showed that antibiotic medications are accessi-
le to the general public and can be bought over the counter in
he GCC countries, which is evident that the regulations are not
trictly applied. For this reason, more regulation enforcement is
eeded.
With the alarming increase in the ABR, alternative therapeu-
ic strategies are urgently needed to overcome this ever-changing
acterial battle. Many studies have revealed that there are
ome certain compounds investigated against infectious diseases
uch as Quorum – sensing inhibitor (QSI) [37,38]. Neverthe-
ess, evidence is accumulating that they may  get resistance
echanism(s) to be similar to those which confer resistance to
ntibiotics [37]. Although, such bioactive molecules do not con-
er resistance behaviour as observed with general antibiotics.
ence, the combinatorial therapy (such as the synergy of QISs
nd antibiotics) is one of the possible revolutionary approaches
o combat the antibiotic resistance crisis in the near future
39].
Some studies, however, have indicated that no single inter-
ention can sufficiently solve the complex problems related
o antibiotic usage [40]. In light of this, a multi-disciplinary
nd multifaceted approach must be put in place to combat
ntimicrobial resistance. For instance, the regulatory measures
nd simultaneous public education campaigns which were con-
ucted in Chile [41] and Zimbabwe [42] have had a great
ffect on controlling the non-prescription sale of antimicrobials,
hich has improved the resistance profiles of diseases. How-
ver, beyond this, tackling antimicrobial resistance needs a global
pproach that recognises the importance of implementing poli-
ies regarding the rational prescription of antimicrobials and
[
[n and Public Health 12 (2019) 159–166 165
regulatory measures by way  of preventing inappropriate consump-
tion.
Conclusion
This systematic review found that nearly half of the general pub-
lic in the Gulf Cooperation Council region lack of knowledge about
antibiotic use and showed negative attitudes towards antibiotic
utilisation. In view of the importance of the world-wide problem of
antimicrobial resistance, these findings let us recognise that there
is still a long way  to go towards a complete awareness of the appro-
priate use of antibiotics by the general public. A multi-disciplinary
approach must be put in place to educate the public on appropriate
antibiotic use, to improve policies regarding the rational prescrip-
tion of antimicrobials and to increase regulation enforcement.
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